Key Events This Week
25 May: Stock surged 6.76% to Rs.137.40 following technical upgrade
26 May: Rating upgraded to Sell from Strong Sell despite weak financials
29 May: Mixed quarterly results reported with record sales but margin pressures
29 May: Week closes at Rs.136.80, up 6.29% for the week

Tyche Industries Q4 FY26: Profitability Concerns Deepen Despite Revenue Recovery
2026-05-29 11:53:02Tyche Industries Ltd., a micro-cap pharmaceutical manufacturer specialising in glucosamine hydrochloride and bulk drug intermediates, reported a challenging quarter for Q4 FY26 (January-March 2026) with net profit of ₹1.15 crores, marking a decline of 36.81% quarter-on-quarter and 22.34% year-on-year. Despite a strong 53.12% sequential revenue recovery to ₹16.20 crores, the company's operating profitability deteriorated sharply, with operating margins turning negative for the first time in recent quarters. The stock, currently trading at ₹138.00 with a market capitalisation of ₹136.00 crores, has gained 3.41% following the results announcement but faces mounting operational headwinds.
Read full news article
Tyche Industries Ltd Reports Mixed Quarterly Results Amid Margin Pressures
2026-05-29 11:03:07Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, reported its quarterly results for March 2026, revealing a nuanced financial performance. While net sales reached a record high of ₹16.20 crores, profitability metrics continued to face headwinds, with operating margins contracting and net profit after tax declining sharply over the past six months.
Read full news article
Tyche Industries Ltd Upgraded to Sell on Technical Improvements Despite Weak Financials
2026-05-26 09:05:15Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 25 May 2026. This change is primarily driven by a shift in technical indicators, even as the company continues to grapple with deteriorating financial performance and expensive valuation metrics.
Read full news articleTyche Industries Falls 4.88%: 2 Key Factors Driving the Weekly Decline
2026-05-23 14:02:26
Key Events This Week
May 18: Valuation shifts amid mixed market performance
May 19: Downgrade to Strong Sell due to deteriorating fundamentals and bearish technicals
May 22: Week closes at Rs.128.70 (-4.88%)
When is the next results date for Tyche Industries Ltd?
2026-05-20 23:19:11The next results date for Tyche Industries Ltd is scheduled for 28 May 2026....
Read full news article
Tyche Industries Downgraded to Strong Sell Amid Deteriorating Fundamentals and Bearish Technicals
2026-05-19 08:54:13Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 18 May 2026. This shift reflects a combination of deteriorating technical indicators, stretched valuation metrics, and a bleak financial trend, signalling caution for investors amid ongoing underperformance relative to benchmarks.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
31-May-2026 | Source : BSENewspaper Publication og Audited Financial Results for the 4th Quarter and Year Ended March 31 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
29-May-2026 | Source : BSEPursuant to Regulation 24A of SEBI(LODR) Regulations 2015 please find enclosed herewith the Annual Secretarial Compliance Report for the Year ended March 31 2026.
Audited Financial Results For The Quarter And Financial Year Ended 31St March 2026
28-May-2026 | Source : BSEAudited Financial Results For the Quarter and Financial Year Ended 31st March 2026.
Corporate Actions
No Upcoming Board Meetings
Tyche Industries Ltd has declared 30% dividend, ex-date: 19 Sep 25
No Splits history available
No Bonus history available
No Rights history available







